PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2

[1]  Peter Nürnberg,et al.  Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. , 2004, American journal of human genetics.

[2]  I. Duncan,et al.  Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia , 2004, The Journal of cell biology.

[3]  E. Jacobs,et al.  Embryonic Expression of the Soma-Restricted Products of the Myelin Proteolipid Gene in Motor Neurons and Muscle , 2004, Neurochemical Research.

[4]  J. Lupski,et al.  Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. , 2004, Human molecular genetics.

[5]  P. Wight,et al.  Where, when and how much: regulation of myelin proteolipid protein gene expression , 2004, Cellular and Molecular Life Sciences CMLS.

[6]  M. Fontès,et al.  Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease , 2004, Nature Medicine.

[7]  J. Lupski,et al.  Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.

[8]  J. Lupski,et al.  Intestinal aganglionosis associated with the Waardenburg syndrome: report of two cases and review of the literature , 2003, Pediatric Surgery International.

[9]  Siddharthan Chandran,et al.  FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway , 2003, Development.

[10]  R. Schiffmann,et al.  Insertion of mutant proteolipid protein results in missorting of myelin proteins , 2003, Annals of neurology.

[11]  M. Filbin,et al.  Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS , 2003, Nature Reviews Neuroscience.

[12]  J. Lupski,et al.  Molecular mechanisms for genomic disorders. , 2003, Annual review of genomics and human genetics.

[13]  K. Nave,et al.  Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) , 2003, Nature Medicine.

[14]  E. Bongarzone,et al.  Expression of soma-restricted proteolipid/DM20 proteins in lymphoid cells , 2003, Journal of Neuroimmunology.

[15]  B. Popko.  Notch signaling: a rheostat regulating oligodendrocyte differentiation? , 2003, Developmental cell.

[16]  E. Jacobs,et al.  Soma-Restricted Products of the Myelin Proteolipid Gene Are Expressed Primarily in Neurons in the Developing Mouse Nervous System , 2003, Developmental Neuroscience.

[17]  Neal N. Iwakoshi,et al.  Proteasome inhibitors disrupt the unfolded protein response in myeloma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  John Q Trojanowski,et al.  ‘Unfolding’ pathways in neurodegenerative disease , 2003, Trends in Neurosciences.

[19]  S. Takashima,et al.  Myelination of a fetus with Pelizaeus–Merzbacher disease: Immunopathological study , 2003, Annals of neurology.

[20]  N. Niikawa,et al.  Functional disomy for Xq22‐q23 in a girl with complex rearrangements of chromosomes 3 and X , 2003, American journal of medical genetics. Part A.

[21]  J. Fink,et al.  The hereditary spastic paraplegias: nine genes and counting. , 2003, Archives of neurology.

[22]  S. High,et al.  Role of calnexin in the glycan‐independent quality control of proteolipid protein , 2003, The EMBO journal.

[23]  P. Ye,et al.  Mouse NG2+ Oligodendrocyte Precursors Express mRNA for Proteolipid Protein But Not Its DM-20 Variant: A Study of Laser Microdissection-Captured NG2+ Cells , 2003, The Journal of Neuroscience.

[24]  H. Moser,et al.  Proton MR Spectroscopic Imaging in Pelizaeus-Merzbacher Disease , 2003, AJNR. American journal of neuroradiology.

[25]  Angelo L. Vescovi,et al.  Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis , 2003, Nature.

[26]  R. Winter,et al.  Complex chromosomal rearrangement and associated counseling issues in a family with Pelizaeus‐Merzbacher disease , 2003, American journal of medical genetics. Part A.

[27]  W. Macklin,et al.  Proteolipid Protein Gene Mutation Induces Altered Ventilatory Response to Hypoxia in the Myelin-Deficient Rat , 2003, The Journal of Neuroscience.

[28]  D. Sammond,et al.  Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein , 2003, Journal of neuroscience research.

[29]  E. Bertini,et al.  Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy , 2003, Annals of neurology.

[30]  K. Nave,et al.  Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.

[31]  J. Lupski,et al.  Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg–Hirschsprung disease: Phenotypes linked by SOX10 mutation , 2002, Annals of neurology.

[32]  Wei Jiang,et al.  The Unfolded Protein Response Modulates Disease Severity in Pelizaeus-Merzbacher Disease , 2002, Neuron.

[33]  J. Garbern,et al.  Prenatal diagnosis of Pelizaeus‐Merzbacher disease , 2002, Prenatal diagnosis.

[34]  H. Marks,et al.  A PLP splicing abnormality is associated with an unusual presentation of PMD , 2002, Annals of neurology.

[35]  L. Shaffer,et al.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. , 2002, American journal of human genetics.

[36]  M. Sospedra,et al.  Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus , 2002, European journal of immunology.

[37]  W. Macklin,et al.  Myelin Proteolipid Protein Forms a Complex with Integrins and May Participate in Integrin Receptor Signaling in Oligodendrocytes , 2002, The Journal of Neuroscience.

[38]  K. Yamakawa,et al.  The Xq22 inversion breakpoint interrupted a novel Ras-like GTPase gene in a patient with Duchenne muscular dystrophy and profound mental retardation. , 2002, American journal of human genetics.

[39]  I. Griffiths,et al.  Survival of, and competition between, oligodendrocytes expressing different alleles of the Plp gene , 2002, The Journal of cell biology.

[40]  I. Verma,et al.  SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism , 2002, Human Genetics.

[41]  J. Schulz,et al.  Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes , 2002, The Journal of cell biology.

[42]  Erik A Sistermans,et al.  Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. , 2002, Brain : a journal of neurology.

[43]  R. Skoff,et al.  Proteolipid Protein Gene Modulates Viability and Phenotype of Neurons , 2002, The Journal of Neuroscience.

[44]  P. Stankiewicz,et al.  Genome architecture, rearrangements and genomic disorders. , 2002, Trends in genetics : TIG.

[45]  S. Tanada,et al.  Brain N-acetylaspartate is elevated in Pelizaeus–Merzbacher disease with PLP1 duplication , 2002, Neurology.

[46]  M. Wegner,et al.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. , 2002, Genes & development.

[47]  B. Trapp,et al.  N‐acetylaspartate is an axon‐specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve , 2002, Annals of neurology.

[48]  L. Shaffer,et al.  Compensating for central nervous system dysmyelination: Females with a proteolipid protein gene duplication and sustained clinical improvement , 2001, Annals of neurology.

[49]  L. Shaffer,et al.  Prenatal interphase FISH diagnosis of PLP1 duplication associated with Pelizaeus–Merzbacher disease , 2001, Prenatal diagnosis.

[50]  W J Schwartz,et al.  Towards the reconstruction of central nervous system white matter using neural precursor cells. , 2001, Brain : a journal of neurology.

[51]  K. Nave,et al.  Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways , 2001, Journal of neurocytology.

[52]  E. Le Guern,et al.  The SOX10 transcription factor: evaluation as a candidate gene for central and peripheral hereditary myelin disorders , 2001, Journal of Neurology.

[53]  R. Schiffmann,et al.  Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations , 2001, Neurology.

[54]  A. Gow,et al.  Molecular Pathways of Oligodendrocyte Apoptosis Revealed by Mutations in the Proteolipid Protein Gene , 2022 .

[55]  G. Fishell,et al.  Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. , 2001, Development.

[56]  S. Malcolm,et al.  The proteolipid protein gene and myelin disorders in man and animal models. , 2000, Human molecular genetics.

[57]  B. Dastugue,et al.  Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations , 2000, European Journal of Human Genetics.

[58]  I. D. de Coo,et al.  Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus–Merzbacher disease , 2000, Neurology.

[59]  M. Simons,et al.  Assembly of Myelin by Association of Proteolipid Protein with Cholesterol- and Galactosylceramide-Rich Membrane Domains , 2000, The Journal of cell biology.

[60]  E. Zackai,et al.  Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome. , 2000, American journal of human genetics.

[61]  K. Woodward,et al.  X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations , 2000, European Journal of Human Genetics.

[62]  V. Friedrich,et al.  The Evolution of Lipophilin Genes from Invertebrates to Tetrapods: DM-20 Cannot Replace Proteolipid Protein in CNS Myelin , 2000, The Journal of Neuroscience.

[63]  Barkovich Aj.  Concepts of Myelin and Myelination in Neuroradiology , 2000 .

[64]  T. Holekamp,et al.  Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  A. Munnich,et al.  Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. , 2000, American journal of human genetics.

[66]  T. Popolizio,et al.  Proton MR spectroscopy in connatal Pelizaeus-Merzbacher disease , 2000, Pediatric Radiology.

[67]  Joanne Chan,et al.  Sonic Hedgehog–Regulated Oligodendrocyte Lineage Genes Encoding bHLH Proteins in the Mammalian Central Nervous System , 2000, Neuron.

[68]  David J Anderson,et al.  Identification of a Novel Family of Oligodendrocyte Lineage-Specific Basic Helix–Loop–Helix Transcription Factors , 2000, Neuron.

[69]  C. ffrench-Constant,et al.  Integrins mediate a neuronal survival signal for oligodendrocytes , 1999, Current Biology.

[70]  J. Takanashi,et al.  MR-revealed myelination in the cerebral corticospinal tract as a marker for Pelizaeus-Merzbacher's disease with proteolipid protein gene duplication. , 1999, AJNR. American journal of neuroradiology.

[71]  E. Jacobs,et al.  Identification of a New Exon in the Myelin Proteolipid Protein Gene Encoding Novel Protein Isoforms That Are Restricted to the Somata of Oligodendrocytes and Neurons , 1999, The Journal of Neuroscience.

[72]  M. Shy,et al.  The molecular pathogenesis of Pelizaeus-Merzbacher disease. , 1999, Archives of neurology.

[73]  J. Lupski,et al.  Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation , 1999, Annals of neurology.

[74]  J. Boire,et al.  Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease. , 1999, American journal of human genetics.

[75]  R. McKay,et al.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants. , 1999, Science.

[76]  T. Ozawa,et al.  A de novo splice donor site mutation causes in‐frame deletion of 14 amino acids in the proteolipid protein in Pelizaeus‐Merzbacher disease , 1999, Annals of neurology.

[77]  L. Shaffer,et al.  Proteolipid protein gene duplications causing Pelizaeus‐Merzbacher disease: Molecular mechanism and phenotypic manifestations , 1999, Annals of neurology.

[78]  J. Nagle,et al.  Novel exon 3B proteolipid protein gene mutation causing late‐onset spastic paraplegia type 2 with variable penetrance in female family members , 1999, Annals of neurology.

[79]  K. Woodward,et al.  Prenatal diagnosis by FISH in a family with Pelizaeus–Merzbacher disease caused by duplication of the PLP gene , 1999 .

[80]  R. Skoff,et al.  Programmed cell death without DNA fragmentation in the jimpy mouse: secreted factors can enhance survival , 1999, Cell Death and Differentiation.

[81]  I. Kanazawa,et al.  Pelizaeus‐Merzbacher disease: Three novel mutations and implication for locus heterogeneity , 1999, Annals of neurology.

[82]  I. Duncan,et al.  Myelin mosaicism and brain plasticity in heterozygous females of a canine X‐linked trait , 1998, Annals of neurology.

[83]  J. Lupski.  Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. , 1998, Trends in genetics : TIG.

[84]  D. Vetrie,et al.  Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH. , 1998, American journal of human genetics.

[85]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[86]  K. Nave,et al.  Current concepts of PLP and its role in the nervous system , 1998, Microscopy research and technique.

[87]  B. V. van Oost,et al.  Duplication of the proteolipid protein gene is the major cause of Pelizaeus‐Merzbacher disease , 1998, Neurology.

[88]  M. Klugmann,et al.  Late‐onset neurodegeneration in mice with increased dosage of the proteolipid protein gene , 1998, The Journal of comparative neurology.

[89]  H. Osaka,et al.  An MRI and MRS study of Pelizaeus-Merzbacher disease. , 1998, Pediatric neurology.

[90]  R. Lazzarini,et al.  Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease , 1998, The Journal of cell biology.

[91]  M. Wegner,et al.  Sox10, a Novel Transcriptional Modulator in Glial Cells , 1998, The Journal of Neuroscience.

[92]  S. Timsit,et al.  In situ expression of PLP/DM‐20, MBP, and CNP during embryonic and postnatal development of the jimpy mutant and of transgenic mice overexpressing PLP , 1997, Journal of Neuroscience Research.

[93]  T. Lehner,et al.  Pelizaeus-Merzbacher-like disease: Exclusion of the proteolipid protein locus and documentation of a new locus on Xq , 1997, Neurology.

[94]  G. Paulson,et al.  Family with Pelizaeus-Merzbacher disease/X-linked spastic paraplegia and a nonsense mutation in exon 6 of the proteolipid protein gene. , 1997, American journal of medical genetics.

[95]  G. Kraft,et al.  Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin , 1997, Neuron.

[96]  J. Valk,et al.  MRI assessment of myelination of motor and sensory pathways in the brain of preterm and term-born infants. , 1997, Neuropediatrics.

[97]  M. Hodes,et al.  Nonsense mutation in exon 3 of the proteolipid protein gene (PLP) in a family with an unusual form of Pelizaeus-Merzbacher disease. , 1997, American journal of medical genetics.

[98]  J. Takanashi,et al.  Proton MR spectroscopy in Pelizaeus-Merzbacher disease. , 1997, AJNR. American journal of neuroradiology.

[99]  K. Nave,et al.  Assembly of CNS Myelin in the Absence of Proteolipid Protein , 1997, Neuron.

[100]  D. Colman,et al.  Conservation of Topology, But Not Conformation, of the Proteolipid Proteins of the Myelin Sheath , 1997, The Journal of Neuroscience.

[101]  K. Mikoshiba,et al.  Myelin Proteolipid Protein (PLP), but Not DM-20, Is an Inositol Hexakisphosphate-binding Protein* , 1996, The Journal of Biological Chemistry.

[102]  M. Nance,et al.  Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease , 1996, Neurology.

[103]  R. Lazzarini,et al.  A cellular mechanism governing the severity of Pelizaeus–Merzbacher disease , 1996, Nature Genetics.

[104]  H. Osaka,et al.  A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. , 1996, American journal of human genetics.

[105]  C. Campagnoni,et al.  Expression of the myelin proteolipid protein gene in the human fetal thymus , 1996, Journal of Neuroimmunology.

[106]  M. Yoshida,et al.  Parallel Evolution and Coexpression of the Proteolipid Proteins and Protein Zero in Vertebrate Myelin , 1996, Neuron.

[107]  K. Mikoshiba,et al.  Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage , 1996, Neuroscience Research.

[108]  D. Barker,et al.  Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia , 1996, Neurology.

[109]  E. Sistermans,et al.  A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family , 1996, Human Genetics.

[110]  H. Osaka,et al.  Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males. , 1995, Biochemical and biophysical research communications.

[111]  W. Stoffel,et al.  Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[112]  F. Seitelberger.  Neuropathology and Genetics of Pelizaeus‐Merzbacher Disease , 1995, Brain pathology.

[113]  C. Readhead,et al.  Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[114]  I. Griffiths,et al.  Expression of the proteolipid protein gene in glial cells of the post‐natal peripheral nervous system of rodents , 1995, Neuropathology and applied neurobiology.

[115]  M. Hodes,et al.  Girl with signs of Pelizaeus-Merzbacher disease heterozygous for a mutation in exon 2 of the proteolipid protein gene. , 1995, American journal of medical genetics.

[116]  L. Puelles,et al.  Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[117]  M. Dolivo,et al.  Paralytic Tremor (pt): A New Allele of the Proteolipid Protein Gene in Rabbits , 1994, Journal of neurochemistry.

[118]  W. Stoffel,et al.  Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[119]  L. Hudson,et al.  A Combination of PLP and DM20 Transgenes Promotes Partial Myelination in the Jimpy Mouse , 1994, Journal of neurochemistry.

[120]  K. Mikoshiba,et al.  Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene , 1994, Neuron.

[121]  W. Richardson,et al.  Embryonic expression of myelin genes: Evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube , 1994, Neuron.

[122]  K. Mikoshiba,et al.  Fate of Jimpy‐Type Oligodendrocytes in Jimpy Heterozygote , 1994, Journal of neurochemistry.

[123]  S. Malcolm,et al.  Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease , 1994, Nature Genetics.

[124]  C. Readhead,et al.  Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage , 1994, Neuron.

[125]  A. Munnich,et al.  X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus , 1994, Nature Genetics.

[126]  K. Kitagawa,et al.  A proteolipid protein gene family: Expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide , 1993, Neuron.

[127]  Yimin Yan,et al.  Molecular cloning of M6: Identification of a PLP/DM20 gene family , 1993, Neuron.

[128]  T. Weimbs,et al.  Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. , 1992, Biochemistry.

[129]  C. Campagnoni,et al.  DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart , 1992, Journal of neuroscience research.

[130]  K. Nave,et al.  Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene , 1992, Nature.

[131]  K. Mikoshiba,et al.  Selective Expression of DM‐20, an Alternatively Spliced Myelin Proteolipid Protein Gene Product, in Developing Nervous System and in Nonglial Cells , 1992, Journal of neurochemistry.

[132]  C. Williams,et al.  Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. , 1991, American journal of human genetics.

[133]  Karli M Nave,et al.  Induction of the myelin proteolipid protein (PLP) gene in C6 glioblastoma cells: functional analysis of the PLP promotor , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[134]  I. Griffiths,et al.  Rumpshaker: an X‐linked mutation affecting CNS myelination. A study of the female heterozygote , 1991, Neuropathology and applied neurobiology.

[135]  J. Popot,et al.  Major myelin proteolipid: The 4-α-helix topology , 1991, The Journal of Membrane Biology.

[136]  I. Duncan,et al.  A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development. , 1990, Development.

[137]  L. Hudson,et al.  Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[138]  M. Hodes,et al.  Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[139]  W. Stoffel,et al.  Myelin‐deficient rat: a point mutation in exon III (A‐‐‐‐C, Thr75‐‐‐‐Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death. , 1989, The EMBO journal.

[140]  J. Berndt,et al.  Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[141]  Professor Dr. Jacob Valk,et al.  Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1989, Springer Berlin Heidelberg.

[142]  R. Skoff,et al.  Expression of the jimpy gene in the spinal cords of heterozygous female mice. 2. Oligodendroglial and endothelial cell hyperplasia. , 1989, Brain research. Developmental brain research.

[143]  F. Bloom,et al.  Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[144]  F. Bloom,et al.  Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[145]  R. Skoff,et al.  Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[146]  R. Skoff,et al.  Expression of the jimpy gene in the spinal cords of heterozygous female mice. I. An early myelin deficit followed by compensation , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[147]  J. Aicardi,et al.  Pelizaeus-Merzbacher Disease: Clinical and Nosological Study , 1986, Journal of child neurology.

[148]  H. Willard,et al.  Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. , 1985, Science.

[149]  J. Rosenfeld,et al.  Axonal swellings in jimpy mice: Does lack of myelin cause neuronal abnormalities? , 1983, Neuroscience.

[150]  A. van Dorsselaer,et al.  Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes. , 1983, European journal of biochemistry.

[151]  W. Demyer,et al.  Pelizaeus-Merzbacher Disease , 2017 .

[152]  V. McKusick,et al.  A sex-linked recessive form of spastic paraplegia. , 1962, American journal of human genetics.

[153]  L. Merzbacher.  Eine eigenartige familiär-hereditäre erkrankungsform (Aplasia axialis extracorticalis congenita) , 1910 .

[154]  Fr. Pelizaeus.  Ueber eine eigenthümliche Form spastischer Lähmung mit Cerebralerscheinungen auf hereditärer Grundlage. (Multiple Sklerose) , 1885, Archiv für Psychiatrie und Nervenkrankheiten.

[155]  A. Barkovich.  Concepts of myelin and myelination in neuroradiology. , 2000, AJNR. American journal of neuroradiology.

[156]  K. Woodward,et al.  Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP gene. , 1999, Prenatal diagnosis.

[157]  W. Richardson,et al.  Origins of spinal cord oligodendrocytes: possible developmental and evolutionary relationships with motor neurons. , 1997, Developmental neuroscience.

[158]  PhD Marjo S. van der Knaap MD,et al.  Magnetic Resonance of Myelin, Myelination, and Myelin Disorders , 1995, Springer Berlin Heidelberg.

[159]  J. Berndt,et al.  Identification of cis-regulatory elements in the myelin proteolipid protein (PLP) gene. , 1992, The Journal of biological chemistry.

[160]  J. Popot,et al.  Major myelin proteolipid: the 4-alpha-helix topology. , 1991, The Journal of membrane biology.

[161]  D. Norman,et al.  Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. , 1988, Radiology.

[162]  D. Simon,et al.  The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice , 1986, Nature.